MARKET

HBIO

HBIO

Harvard Biosci
NASDAQ
5.09
+0.22
+4.52%
Closed 19:24 04/01 EDT
OPEN
4.860
PREV CLOSE
4.870
HIGH
5.30
LOW
4.860
VOLUME
95.69K
TURNOVER
0
52 WEEK HIGH
9.46
52 WEEK LOW
2.813
MARKET CAP
22.76M
P/E (TTM)
-0.3985
1D
5D
1M
3M
1Y
5Y
1D
Harvard Bioscience CFO Makes Bold Insider Move Signaling Confidence Ahead
TipRanks · 6h ago
Harvard Bioscience CFO Mark Frost acquires $25,000 common shares
Reuters · 19h ago
Weekly Report: what happened at HBIO last week (0323-0327)?
Weekly Report · 2d ago
Weekly Report: what happened at HBIO last week (0316-0320)?
Weekly Report · 03/23 10:17
Harvard Bioscience Directors Make Bold Insider Moves That Could Signal What’s Coming Next
TipRanks · 03/19 02:05
Harvard Bioscience Director Stephen J DeNelsky Acquires USD 48,700 in Common Shares
Reuters · 03/18 18:13
Harvard Bioscience Director William Snider Acquires USD 103,000 of Common Shares
Reuters · 03/18 11:32
Harvard Bioscience CEO Makes Bold Insider Move With Fresh Stock Purchase
TipRanks · 03/18 02:07
More
About HBIO
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. Its CMT product family includes the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS and Warner brands. Its Preclinical product family provides a complete platform to assess physiological data from organisms for research ranging from basic research to drug discovery, and drug development services. The Preclinical Product family includes the DSI, Panlab, Hugo Sachs and Buxco brands.

Webull offers Harvard Bioscience Inc stock information, including NASDAQ: HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.